Related Experiment Video

Updated: Feb 1, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer

Wan-Chi Hsiao1, Shian-Ying Sung1,2,3, Leland W K Chung4

  • 1The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.

Methods in Molecular Biology (Clifton, N.J.)
|December 13, 2018
PubMed

Insights

Herpes simplex virus thymidine kinase (HSV-tk) suicide gene therapy with ganciclovir (GCV) shows promise for prostate cancer. This study details methods to evaluate osteonectin promoter-driven HSV-tk/GCV therapy

Area of Science:

  • Oncology
  • Gene Therapy
  • Biotechnology

Background:

  • Suicide gene therapy offers a targeted approach for cancer treatment.
  • Herpes simplex virus thymidine kinase (HSV-tk) combined with ganciclovir (GCV) is a key suicide gene therapy system.
  • Prostate cancer treatment requires specific gene expression and efficient delivery for efficacy.

Purpose of the Study:

  • To describe methodologies for evaluating osteonectin promoter-mediated HSV-tk/GCV suicide gene therapy for prostate cancer.
  • To assess the specificity and efficacy of this gene therapy approach.

Main Methods:

  • Construction and validation of promoter elements.
  • Reporter gene assays to confirm promoter activity.
  • Adenoviral vector preparation and characterization.
  • Enzymatic assays for HSV-tk activity.
  • Cytotoxicity assays to determine therapeutic effect.

Main Results:

  • Detailed protocols for key experimental procedures are provided.
  • Methodologies allow for evaluation of promoter specificity and gene delivery efficiency.
  • The study lays the groundwork for assessing HSV-tk/GCV therapy efficacy in prostate cancer models.

Conclusions:

  • The described methodologies are crucial for advancing HSV-tk/GCV suicide gene therapy.
  • Osteonectin promoter-mediated gene therapy holds potential for targeted prostate cancer treatment.
  • Further research using these protocols can optimize this therapeutic strategy.
Keywords:
Adenoviral vectorHSV-tk enzymatic assayOsteonectin promoter constructionProstate cancerSuicide gene therapy

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.9K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K